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Abstract
Cardiac stem cells (CSCs) can home to the infarcted area and regenerate myocardium. Stromal cell-derived factor-1a/C-X-C
chemokine receptor type 4 (SDF-1a/CXCR4) axis is pivotal in inducing CSCs migration. However, the mechanisms remain
unclear. This study set out to detect if SDF-1a promotes migration and engraftment of CSCs through the CXCR4/PI3K
(phosphatidylinositol 3-kinase) pathway. In the in vitro experiment, c-kit+ cells were isolated from neonatal mouse heart
fragment culture by magnetic cell sorting. Fluorescence-activated cell sorting results demonstrated that a few c-kit+ cells
expressed CD45 (4.54%) and Sca-1 (2.58%), the hematopoietic stem cell marker. Conditioned culture could induce c-kit+
cells multipotent differentiation, which was confirmed by cardiac troponin I (cTn-I), a-smooth muscle actin (a-SMA), and von
Willebrand factor (vWF) staining. In vitro chemotaxis assays were performed using Transwell cell chambers to detect CSCs
migration. The results showed that the cardiomyocytes infected with rAAV1-SDF-1a-eGFP significantly increased SDF-1a
concentration, 5-fold more in supernatant than that in the control group, and subsequently attracted more CSCs migration.
This effect was diminished by administration of AMD3100 (10 mg/ml, CXCR4 antagonist) or LY294002 (20 mmol/L, PI3K
inhibitor). In myocardial infarction mice, overexpression of SDF-1a in the infarcted area by rAAV1-SDF-1a-eGFP infection
resulted in more CSCs retention to the infarcted myocardium, a higher percentage of proliferation, and reduced infarcted
area which was attenuated by AMD3100 or ly294002 pretreatment. These results indicated that overexpression of SDF-1a
enhanced CSCs migration in vitro and engraftment of transplanted CSCs and reduced infarcted size via CXCR4/PI3K
pathway.
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Introduction
Myocardial infarction (MI) is one of the leading causes of death
and the ischemic injury is usually irreversible despite aggressive
medical and revascularization treatment. Previous studies have
shown that cardiac stem cells (CSCs) can differentiate into
cardiomyocytes, smooth muscle cells or endothelial cells [1–4].
Therefore, transplantation of CSCs can reduce infarcted size and
enhance heart function [1,5–7], representing a new strategy for
cardiac repair. At present, a variety of CSCs have been reported
and classified according to biological markers such as c-kit+, side
population and Islet-1+ [3,8]. C-kit [9], also called KIT or
CD117, is a cytokine receptor expressed on the surface of multiple
stem cells. The c-kit+ CSCs represent one of the major CSCs
populations which have properties of multidirectional differenti-
ation [2,3]. Animal and human studies [10–15] indicate that
transplantation of c-kit+ CSCs reduces infarcted size and improves
cardiac function of MI. However, the mechanism of c-kit+ CSCs
homing to the infarcted zone is not clear.
Migration is a critical process for stem cells recruitment into
target area and tissue repairing. Up to now, stromal cell-derived
factor-1a (SDF-1a) and its cellular receptor CXCR4 (C-X-C
chemokine receptor type 4) are known as the most prominent stem
cell chemotaxis. SDF-1a has been shown to be significantly
upregulated in many experimental models including myocardial
infarction [5,16] and attract the CXCR4+ stem cells towards SDF-
1a gradient. Thus, upregulation of SDF-1a expression in ischemial
myocardium represents a promising therapeutic strategy to
improve post-infarction therapy. Recently, Tang et al [17]
reported that exogenously expressed vascular endothelial growth
factor (VEGF) promoted myocardial repair at least in part through
SDF-1a/CXCR4-mediated migration of CSCs. However, the role
of SDF-1a/CXCR4 pathway in CSCs migration needs to be
further clarified.
Phosphatidylinositol 3-kinase (PI3K) is widely expressed and
plays crucial roles in regulating multiple cell processes, such as cell
migration, proliferation, differentiation, motility, survival and
angiogenesis [18–20]. There are two distinct activities that PI3K
participates in, phosphorylation of the regulatory subunit by the
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catalytic subunit and lipid phosphorylation. PI3K facilitates the
transformation of phosphatidylinositol-3, 4-bisphosphate (PIP2)
into phosphatidylinositol-3, 4, 5-trisphosphate (PIP3) which
retrieves pleckstrin homology (PH) domain-containing proteins
such as Akt to the cell membrane. Previous studies have
demonstrated PI3K is also involved in SDF-1a/CXCR4-mediated
chemotaxis and multiple stem/progenitor cells migration
[18,19,21]. Overexpression of VEGF resulted in CSCs migration
and homing to the injured myocardium, which was inhibited by
the PI3K/Akt inhibitor [17].
The purpose of this study was to address the following questions:
1) whether overexpression of SDF-1a resulted in CSCs migration
and accumulation in the infarcted region, and 2) whether SDF-1a-
induced CSCs migration was mediated via CXCR4/PI3K
signaling pathway.
Materials and Methods
Ethics statement
Animal experiments were approved by the Institutional Animal
Care and Use Committee of Third Military Medical University.
All the procedures were in compliance with the National Institute
of Health Guide for the Care and Use of Laboratory Animals
(NIH Publications No. 80-23).
Isolation and culture of c-kit+ CSCs
C-kit+ cardiac stem cells were isolated from neonatal Bab/c
mice (3–5 d) according to previous methods [2,3,22,23]. Briefly,
mouse hearts were removed and minced into small pieces, washed
with phosphate buffered solution (PBS) and digested 3 times for
5 min at 37uC with a mixture of 0.2% trypsin (Invitrogen) and
0.1% collagenase IV (Sigma). Cells were filtered through 80-mm
mesh and the remaining tissue fragments were washed with PBS
and cultured as explants in complete explant medium (CEM)
[IMDM(HyClone) supplemented with 10% fetal bovine serum
(FBS) (Gibco), 100 Units/ml penicillin G, 100 mg/ml streptomy-
cin, 2 mmol/L L-glutamine (Invitrogen) and 0.1 mmol/L 2-
Mercaptoethanol (Sigma)] at 37uC and 5% CO2.
After 10 to 20 days, a layer of small, phasebright cells above the
adherent explants were collected by washing with 0.5 g/L
Trypsin-0.53 mmol/L EDTA. The cell suspension was filtered
through a 40-mm cell strainer and isolated by magnetic cell sorting
(MACS, Miltenyi Biotec) using anti-c-kit-coupled magnetic beads
(Miltenyi Biotec).
The purified c-kit+ cells were seeded at 0.5–26105/ml in
multiwell plates precoated with fibronectin in CGM(cardiosphere-
growing medium) with minor modification [2,23] [Dulbecco’s
MEM and Ham’s F12 (ratio 1:1, HyClone), 10% FBS, basic
fibroblast growth factor (bFGF,10 ng/mL, Invitrogen), epidermal
growth factor (EGF,20 ng/mL,Peperotech Inc), B27 (Invitrogen),
thrombin (40 nmol/L,Sigma), LIF(1000 U/ml, Millipore), insu-
lin–transferrin–selenite (Sigma), penicillin–streptomycin as in
CEM ] at 37uC and 5% CO2.
Flow cytometric analysis
Cells phenotypes were analyzed by fluorescence-activated cell
sorting (FACS). For this purpose, purified c-kit+ cells were co-
incubated for 30 min in the dark at room temperature with the
following antibodies: phycoerythrin (PE)-conjugated antibodies
against CXCR4, Sca-1 or CD45 (from BD Biosciences), and
FITC-conjugated antibodies against c-kit. PE- or FITC-conjugat-
ed isotype IgG were used as control.10,000 to 50,000 cells were
collected and subjected to flow cytometry using BD LSRII flow
cytometer (BD Biosciences).
Multiple differentiation of c-kit+ cells [23]
The purified c-kit+ CSCs were identified by immunofluores-
cence using a monoclonal antibody for c-kit. To induce in vitro
differentiation [3], c-kit+ cells were seeded on 35-mm dish-
es(56104/dish) in DMEM [supplement with 10% FBS, 1 mM
dexamethasone (Sigma), 50 mg/mL ascorbic acid (Sigma) and
1 mM b-glycerophosphate (Sigma)]. The medium was changed
twice a week. Immunofluorescence analysis was performed with
primary antibodies specific for cardiac troponin I (cTn-I) (1:200,
Santa Cruz), a smooth muscle actin (a-SMA) (1:200, Zymed Lab)
and von Willebrand factor (vWF) (1:200, BD PharMingen). Goat
anti-rabbit second antibody conjugated with FITC and TRITC
were used for immunocytochemistry staining. Staining was
observed by a Leica fluorescence microscopy (TCS SP5, Leica).
rAAV1-SDF-1a-eGFP vector construction
Vector production, harvest, purification and testing were
carried out as previously described [24]. The 267 bp mouse
SDF-1a cDNA fragments combining with 3 bp stop codons were
synthesized and amplified through polymerase chain reaction
(PCR), inserted into the cloning sites between SalI and Bgl II in
plasmid pSNAV2.0-mCMV-eGFP to construct the recombinant
expression plasmid pSNAV2.0-SDF-1a-eGFP. The recombinant
plasmid pSNAV2.0-SDF-1a-eGFP was co-transfected into
HEK293 cells with the control plasmid pAAV-R2C1 and pHelper
in AAV Helper-Free System for packaging of recombinant AAV.
The efficiency of rAAV packaging was monitored under
fluorescent microscope and recombinant viral particles were
harvested from infected 293 cells. Viral titers were determined
by dot blot analysis of DNA content and expressed as genome
copies (gcs).
Primary culture of neonatal mouse cardiomyocytes and
rAAV infection
Neonatal mouse cardiomyocytes were isolated from 3–4 day
Bab/c mice by adherence separation method [4]. Hearts were
minced and digested at 37uC in 0.125% trypsinase and 0.08%
collagenase II (sigma). Isolated cells were suspended in DMEM-L
comprising 20% FBS, HEPES, L-glutamine and antibiotics. After
2 hours of adherence, cell suspensions were seeded in 24-well
plates at a density of 16105 cells per well in a humidified
condition. Two days later, the cardiomyocytes were infected with
rAAV1-SDF-1a-eGFP at a MOI of 104.
Migration analysis
The migration of c-kit+ CSCs was assessed using 24-well
transwell with an 8-mm pore size (Millipore) [25]. Cardiac
myocytes were seeded on lower chamber and infected with
rAAV1-SDF-1a-eGFP (infection group). Control group was
infected with empty vector rAAV1-eGFP. Three days later,
56104 c-kit+ CSCs were added into the upper chamber. Migrated
cells were stained with DAPI (Invitrogen) and counted in 10 high-
power microscopic fields 24 hours later. For inhibition experi-
ments, CSCs were pre-incubated with AMD3100 (10 mg/ml,
Sigma–Aldrich) or LY294002 (20 mmol/L, Beyotime) for 1 h
before seeding.
The SDF-1a protein concentration in lower chamber superna-
tant was determined by ELISA assay (R&D Systems) according to
the manufacturer’s instruction.
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Myocardial infarction model, CSCs and rAAV vectors
injection
Mice were anesthetized by 1% pentobarbital (50 mg/kg, i.p.)
and the left anterior descending coronary artery (LAD) was ligated
by the 8-0 nonabsorbable surgical suture [26]. Myocardial
infarction was verified by color change in the ischemic area.
The mice were then divided into 6 groups: 1. Sham group: the
mice chest was opened but without LAD ligation. 2. MI group:
ligation of LAD but without other treatment.3. Control (Empty)
group: 50 ml empty vector and 16105 DAPI-labeled c-kit+ CSCs
in 50 ml saline were injected into infarcted zone and infarcted
border individually, with a 30 G needle at four points. 4. SDF-1a
group: 50 ml rAAV1-SDF-1a-eGFP (2.2561012 gcs/ml) and
16105 DAPI-labeled c-kit+ CSCs were injected in similar way.
5. AMD3100 group: 50 ml rAAV1-SDF-1a-eGFP injection and
16105 DAPI-labeled c-kit+ CSCs transplantation, however, pre-
incubated with AMD3100 (10 mg/ml) for 1 hour. 6. LY294002
group: 50 ml rAAV1-SDF-1a-eGFP injection and 16105 DAPI-
labeled c-kit+ CSCs transplantation, however, pre-incubation with
LY294002 (20 mmol/L) for 1 hour.
The infection efficiency was evaluated by detection of GFP
expression under confocal fluorescent microscope at day 21 and
detection of SDF-1a expression by western blot respectively at
day0, 4, 7, 14, and 21.
Assessment of CSCs engraftment
To detect the engraftment of CSCs in vivo, 16105 DAPI-labeled
c-kit+ CSCs in 50 ml saline were injected into infarcted border
with a 30 G needle after coronary ligation. Three weeks after
ligation, immunofluorence was performed in infarcted regions to
detect the engraftment of DAPI-labeled cells. In vivo differentiation
of CSCs was tested by immunohistochemistry using cTn-I
antibody [27]. Ten confocal images were counted for engraftment
and differentiation assay.
Proliferation analysis of transplanted c-kit+ CSCs
Before being transplanted, c-kit+ CSCs were incubated with
BrdU for 24 hours. Myocardial infarction model, rAAV-SDF-1a-
eGFP injection and CSCs transplantation were operated as above.
Three weeks later, BrdU was detected by immunofluorescent
using a monoclonal antibody in border zones and infarcted region.
The proliferation percentage of transplanted c-kit+ CSCs was
caculated as the percentage of BrdU-positive nuclei vs total DAPI-
stained nuclei.
Infarcted size measurement
At day 21 post-MI, the infarcted size was measured by
triphenyltetrazolium chloride (TTC) staining (n = 6) [28]. Briefly,
the hearts were sliced transversely from the apex to base into 5
sections. Then, they were incubated for 30 min in 2% TTC
(Sigma) solution at 37uC and fixed in 4% paraformaldehyde
overnight. The infarcted myocardium (negative for TTC staining,
white) and the non-ischemic zones (stained brick red) were divided
and weighed. The infarction proportion was counted by ratio of
infarcted mass/total heart.
Western blotting
The expression of SDF-1a in infected zone was determined by
western blot in 3 weeks. The mean densities of the bands were
represented as the OD in units per square millimeter and
normalized by GAPDH. The ratio of OD value of each group
with control group served as the intensity of SDF-1a expression.
Statistics
The data were analyzed using the SPSS 15.0 software.
Continuous variables were expressed as mean 6 SD. Multiple
groups comparison was performed by one-way ANOVA followed
by the Bonferroni procedure for comparison of means. A value of
p,0.05 was considered significant.
Results
Culture of explants and c-kit+ CSCs
Five days after the heart tissues culture, fibroblasts migrated
from the adherent explants. Then, some small, round and phase-
bright cells appeared (Fig. 1A). After c-kit+ MACS isolation, these
c-kit+ positive cells (green, Fig. 1B) were seeded in CGM and
gradually formed three-dimensional spheres in 2 weeks (Fig. 1C).
Multipotent differentiation of c-kit+ CSCs
C-kit+ cells changed their shape in conditioned culture.
Confocal immunofluorescence analysis showed expression of
cTn-I(green, Fig. 1D), cardiomyocyte specific protein, a-SMA
(red, Fig. 1E), smooth muscle specific marker, and the endothelial
specific marker-vWF(red, Fig. 1F).
Flow cytometry analysis of cell surface markers
FACS of CD45, Sca-1 and CXCR4 co-stained with FITC-
conjugated c-kit before MACS isolation were shown in Figure S1.
However, 97% cells were c-kit positive after MACS isolation, and
a few c-kit+ cells expressed CD45 (4.5461.79%, Fig. 1G) and Sca-
1 (2.5861.16%, Fig. 1H), the marker of hematopoietic stem cells,
indicating non-hematopoietic origin. Furthermore, we found high
expression of CXCR4 (91.4767.73%, Fig. 1I), the receptor of
SDF-1a, in purified c-kit+ CSCs (n= 3). Controls with appropriate
isotypes were shown in Fig. 1 J, K and L respectively.
SDF-1a/CXCR4 induced CSCs migration via PI3K pathway
The determinations of recombinant plasmid pSNAV2.0-SDF-
1a-eGFP and recombinated AAV1-SDF-1a-eGFP are shown in
Supplementary Material S1. rAAV1-SDF-1a-eGFP construction
was verified by PCR and immunofluorescence after infection
(Figure S2). Three days after infection, over 90% cardiomyocytes
expressed GFP and SDF-1a. (Figure S2).
ELISA assay indicated that significant higher SDF-1a concen-
tration in infection group than control group (10.2761.8 ng/ml
vs. 2.2360.67 ng/ml, p,0.01, n = 3). Also, there was no
difference among SDF-1a, AMD3100 and LY294002 group
(10.2761.7 ng/ml vs. 10.9761.8 ng/ml and 9.6762.2 ng/ml,
p.0.05, n = 3) (Fig. 2A). Overexpression of SDF-1a attracted
more c-kit+ CSCs migration (infection vs. control group, 48.367.6
vs. 21.366.1, p,0.01). This effect was diminished by AMD3100
(29.766.0 vs. 48.367.6, p,0.05) and LY294002 (26.065.6 vs.
48.367.6, p,0.05) incubation (Fig. 2B).
SDF-1a/CXCR4 induced CSCs engraftment via PI3K
pathway
The efficiency of in vivo rAAV1-SDF-1a-eGFP infection is
shown in Supplementary Material S1. Confocal fluorescence
microscopy showed GFP expression in injected area (Figure S3A),
indicating successful infection of rAAV1-eGFP and rAAV1-SDF-
1a-eGFP. Also, SDF-1a expression peaked at day 14 and
remained 2-fold elevated at day 21. (Figure S3B)
Western blot revealed that there was no difference of SDF-1a
expression between MI and Empty group. However, infection
with rAAV1-SDF-1a-eGFP significantly increased SDF-1a
SDF-1a/CXCR4 Promotes CSCs Homing via PI3K
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expression in infarcted myocardium (SDF-1a vs. MI, 2.2260.38
vs. 1.2060.19, p,0.01, SDF-1a vs. Empty, 2.2260.38 vs.
1.3060.17, p,0.01) at day 21. There was no difference among
SDF-1a, AMD3100 and LY294002 groups (2.2260.38 vs.
2.0860.25 and 2.0260.31, p.0.05, n= 3) (Fig. 3A).
Immunofluorence staining showed more CSCs in the infarcted
regions in SDF-1a group (SDF-1a vs. Empty, 30.366.5 vs.
10.362.5, p,0.01 n= 6). However, the number of CSCs
decreased in AMD3100 (AMD3100 vs. SDF-1a, 8.761.5 vs.
30.366.5, p,0.01) and LY294002 group (LY294002 vs. SDF-1a,
8.062.0 vs. 30.366.5, p,0.01) (Fig. 3B).
Proliferation and differentiation of transplanted CSCs
Proliferation of transplanted CSCs was determined by Brdu/
DAPI double staining. Immunofluorence staining showed more
BrdU positive cells in the infarcted regions in SDF-1a group than
Empty group (SDF-1a vs. Empty, 28.861.5 vs. 8.961.8, p,0.01
n=6) (Fig. 4). However, the cells number decreased in AMD3100
(7.761.7, p,0.01 vs. SDF-1a) and LY294002 group (7.960.9,
p,0.01 vs. SDF-1a). Furthermore, more proliferated cells were
detected in infarcted region in SDF-1a group than border zone
(p,0.05) which contribute to the smaller infarcted area. There
was no difference in border zone among all the groups.
To identify differentiation of CSCs, cTn-I staining was
performed (Figure 5, red). Immunofluorence staining showed
more DAPI-labeled cells around high density of green fluorescence
which confirmed that overexpression of SDF-1a induced CSCs
migration. Furthermore, we found that some DAPI-labeled CSCs
were positive for cTn-I (red), indicating differentiation of homing
CSCs into cardiomyocytes. Evidence for formation of novel
myocytes was detected by the double positive of cTn-I and DAPI.
However, we found that there was no difference of CSCs
differentiation percentage among 4 groups in infarcted zone.
Figure 1. Culture and characterization of c-kit+ CSCs. A. small, round, phase-bright cells appeared. B. Purified c-kit+ cells were positive for c-kit
staining (green). C. Phase-bright cells formed three-dimensional spheres. Multiple differentiation of c-kit+ cells into cardiomyocyte (D, green) smooth
muscle (E, red), and endothelial cells (F, red). DAPI stained nuclei (blue). FACS analysis of c-kit+ cells phenotype with CD45 (4.54%61.79%, G), Sca-
1(2.58%61.16%, H) and CXCR4 (91.47%67.73%, I) (n = 3).
doi:10.1371/journal.pone.0043922.g001
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SDF-1a/CXCR4 reduced MI size via PI3K pathway
TTC staining revealed empty vector infection didn’t improve
infarcted size (Empty vs. MI group, 30.064.0% vs. 27.363.2%,
p.0.05, n= 6). However, rAAV-SDF-1a injection resulted in
reduced infarcted size (SDF-1a vs. MI group, 17.362.5% vs.
27.363.2%, p,0.05, n= 6). This effect was abolished by
AMD3100 pretreatment (SDF-1a vs. AMD3100 group,
17.362.5% vs. 24.063.0%, p,0.05, n = 6) and LY294002
pretreatment (SDF-1a vs. LY294002 group, 17.362.5% vs.
25.363.1%, p,0.05, n = 6) (Fig. 6).
Discussion
Cardiac myocytes have been traditionally regarded as termi-
nally differentiated cells that can be adapted to increased work and
compensate for disease exclusively through hypertrophy [1–3]. In
the past few years, compelling evidence proves that the heart has
regenerative potential [1,22]. Several types of CSCs have been
recently identified according to the expression of some stem cell-
related antigens including c-kit, MDR1, side population, Sca-1,
Flk-1 or islet-1 [3,9,23,29]. In vitro data have suggested that c-kit+
CSCs have a stronger growth potential than other types, although
all of these CSCs categories can give rise to all cardiac cell lineages
[9]. Recently, initial results of a randomized phase 1 trial [11]
suggested intracoronary infusion of autologous c-kit+ CSCs was
effective in improving LV systolic function and reducing infarcted
size after myocardial infarction, thus, demonstrating that c-kit+
CSCs might be a perspective candidate for MI therapy.
Because there are no adequate resident CSCs to replace injured
heart issue after MI [4,10,23,29,30], it is crucial to purify and
expand CSCs in vitro for cardiac repair. We showed that c-kit+ cells
kept their capacity for self-renewal and clonogenic in vitro with
CGM medium, and could differentiate into cardiomyocytes,
endothelial cells and smooth muscle cells. FACS analysis showed
that they were not hematopoietic stem cells.
SDF-1a is a member of the CXC or a chemokine subfamily and
the only known ligand for the chemokine receptor CXCR4 [19].
SDF-1a is constitutively expressed in a large number of tissues and
plays an important role in multiple stem cells migration by binding
CXCR4 [5,16,17,19,25]. Yu et al reported that MI in rat hearts
led to an increased expression of SDF-1a, which mediated
migration of BMSCs through SDF-1a/CXCR4 and activation
of PI3K/Akt [18]. However, the role of SDF-1a/CXCR4
pathway in CSCs migration is still needed to be further clarified.
a et al reported SDF-1a expression was significantly higher within
4 days post operation in the MI groups and peaked at 1 day post
MI [31]. In our present study, we did not observed a high
expression of SDF-1a in the Empty and MI groups at day 21 after
MI which might be due to the death of infarcted myocardium.
Also, previous study found that myocardial infarction increased
expression of SDF-1a mRNA by 56.7% and 95.7% at 48 and
72 hours, respectively, and returned to baseline by 7 days. SDF-1a
protein level peaked at 72 hours and remained 2-fold elevated at
96 hours [32]. Thus, the SDF-1a expression in infarcted zone
decreased rapidly and it is reasonable that endogenous SDF-1a is
not sufficient for CSCs engraftment and myocardial repair in
chronic phase-a suitable time for stem cells survival after acute
inflammatory response. Recently, Tang et al [33] reported that
exogenously expressed VEGF promoted myocardial repair at least
in part through SDF-1a/CXCR4-mediated recruitment of CSCs.
Considering of rare CSCs in the heart, we focused on the effect
of CSCs transplantation in combination with exogenously
Figure 2. SDF-1a/CXCR4 induced CSCs migration via PI3K pathway. A. rAAV1-SDF-1a-eGFP infection increased SDF-1a concentration in
supernatant. *p,0.01 vs. control. n = 3. B. SDF-1a-induced CSCs migration was inhibited by AMD3100 and LY294002. *p,0.01 vs. control. #p,0.05
vs. infection group. Data were shown as mean 6 SD. n = 3.
doi:10.1371/journal.pone.0043922.g002
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overexpression of SDF-1a in chronic phase after MI, which might
be better associated with clinical feasibility.
Our result suggests that SDF-1a overexpression in vivo could
promote the engraftment of the locally transplanted CSCs into the
infarcted region and cardiac repair. Blocking CXCR4 with
AMD3100 can eliminate these effects, indicating an essential role
of SDF-1a/CXCR4 axis in CSCs migration and recruitment.
CXCR4 is a Gi-coupled receptor. Studies have shown that SDF-
1a, after binding to CXCR4, causes mobilization of calcium,
decreases of cyclic AMP within the cells, and activates multiple
signaling pathways such as PI3K [34]. The activation of the PI3K-
Akt pathway can occur as a result of G-protein-coupled receptor
triggering- through direct interaction with the active G protein bc
subunit, or indirectly, by a subunit-induced tyrosine kinase activity
[35]. PI3K catalyzes the phosphorylation of membrane phospha-
tidylinositols generating phosphatidylinositol mono-, bis-, and tris-
phosphate [36]. These products recruit the protein kinase Akt by
interacting with its PH domain and facilitate its phosphorylation
on threonine 308 and serine 473 by phosphoinositide-dependent
kinase 1 and 2 [37]. Ultimately, SDF-1a-bound CXCR4 induces
cytoskeletal rearrangement, adhesion to endothelial cells, polarized
migration of cells to specific organs and the secretion of
angiopoietic factors, all important components of the repair
process [38,39].
Although previous experiment has provided direct evidence that
the PI3K pathway is required for SDF-1a-induced cell migration
in HPC, BMSC [16,18] and VEGF-induced CSCs migration [17],
there are no related report involving SDF-1a action on CSCs. We
found that administration of the specific PI3K inhibitor LY294002
significantly inhibited the SDF-1a-induced CSCs migration and
engraftment, indicating the important role of PI3K pathway.
Furthrmore, as a known downstream effector of the PI3K
dependent signaling cascade, Akt is required for SDF-1a-mediated
chemotaxis, cell proliferation and regulation of intergrin
[18,19,40] and thus may play a role in SDF-1a/CXCR4 mediated
CSCs migration and recruitment.
In addition to CSCs, stem cells and/or progenitors from the bone
marrow, such as mesenchymal stem cells (MSCs) [18], hematopoi-
etic stem cells (HSCs), and endothelial progenitor cells (EPCs)
[16,19], may be recruited to participate in the repair process of
ischemic myocardium through SDF-1a/CXCR4 axis. Thus, the
beneficial effects of SDF-1a overexpression on myogenesis and
angiogenesis in the ischemic heart, as demonstrated in our
experiments, may also involve these cells from extracardiac sources.
Figure 3. SDF-1a/CXCR4 induced CSCs homing via PI3K pathway. A. Western blotting analysis of SDF-1a expression in the infarcted zone 3
weeks after coronary artery ligation or sham operation (the ratio of SDF-1a expression vs. Sham group). * p,0.05 vs. Sham, MI and Empty (vector)
group. GAPDH served as an internal control. Data were shown as mean 6 SD. n = 3. B. SDF-1a Induced the CSCs Homing. Overexpression of SDF-1a
induced DAPI-labeled CSCs homing to the infarcted zone. This effect was inhibited by AMD3100 and LY294002 pretreatment. * p,0.01vs. Empty,
AMD(AMD3100) and LY(LY294002) group. Results were shown as mean 6 SD, n = 6.
doi:10.1371/journal.pone.0043922.g003
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Figure 4. Proliferation of transplanted CSCs. A. proliferation of transplanted CSCs was determined by Brdu and DAPI double staining (red and
blue) 3 weeks after myocardial infarction. Scale bar = 10 mm. B. Quantitative analysis of the ratio of Brdu/DAPI double positive cells. Data were shown
as mean 6 SD. * P,0.01 vs. Empty, AMD and LY group in infarcted zone. n = 6.
doi:10.1371/journal.pone.0043922.g004
Figure 5. Differentiation of transplanted CSCs in infarcted zone. A. differentiation of transplanted CSCs was determined by cTn-I and DAPI
double staining (red and blue) 3 weeks after myocardial infarction. Scale bar = 10 um. B. Quantitative analysis of the ratio of cTn-I/DAPI double
positive cells. Data were shown as mean 6 SD. n = 6.
doi:10.1371/journal.pone.0043922.g005
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We also detected the fate of transplanted CSCs 3 weeks after
MI. Although there was no difference of differentiated CSCs
among 4 groups in infarcted area, more proliferated CSCs in
infarcted zone in SDF-1a group were disclosed than other groups.
It could be the reason of improved infarcted size after SDF-1a
overexpression.
In conclusion, the present study showed that overexpression of
SDF-1a induced CSCs migration in vitro and engraftment of
transplanted CSCs and reduced infarcted size via CXCR4/PI3K
pathway which representing a novel therapeutic strategy for MI.
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